Primary Care POC Diagnostics Market Size , Share, Trends, Revenue Growth And Forecast To 2025| Grand View Research, Inc
“The global primary care POC diagnostics market size was estimated at USD 6.3 billion in 2016.”
The global primary care POC diagnostics market size is expected to reach USD 8.6 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.5% CAGR during the forecast period. Flexible and forwardthinking core molecular labs have been embracing and supporting the use of POC tests to move screening of many common targets to hospital receiving rooms and physicians’ offices. As per a study conducted by the American Journal of Clinical Pathology in 2014, it was found that POC testing improved clinical operations for manufacturers by reducing follow-up calls and letters of patients by 85.0% and 89.0%, respectively, and reducing their follow-up visits by 61.0%. It was also observed that the number of tests ordered decreased by 21.0%. Furthermore, rise in the number of tests receiving a waived status under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) is anticipated to aid market growth. Researchers and manufacturers are increasingly recommending these tests owing to cost reduction of about USD 12-15 per patient and reduction in follow up tests by about 50.0%. However, there is a massive overlap between different methods and their areas of usage. For instance, panels to measure glucose and quick international normalized ratio tests were originally meant for selftesting but are now used in hospitals and primary settings instead.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/primary-care-poc-diagnosticsmarket
Follow Us:
Further key findings from the report suggest: By product, the glucose testing segment accounted for the largest market share owing to rising availability of a large number of products for glucose testing that can be employed within primary care settings
Increase in out-patient practices for lipid testing as part of a routine checkup is expected to positively enhance the adoption rate of lipid testing in the market, giving it a prominent spot in the overall market by product
In terms of end use, while collaborative research for advanced and more accurate POC testing kits by research institutes and biotech firms is likely to facilitate the physicians’ office segment, government initiatives and projects to extend primary care facilities will boost the non-practice clinics segment
The North America primary care POC diagnostics market is more developed compared to the rest of the world. The regional segment is fueled by availability of several innovative and advanced POC diagnostic products and growing awareness and demand for point-of-care diagnostics in primary home healthcare and assisted healthcare
The U.S. market is witnessing a shift toward increasing patient involvement in home care, home-based tests, and monitoring instruments. In addition, digitalization, EHR, telemedicine, and web-enabled solutions of monitoring data are gaining pace in U.S., thereby driving its growth
Some of the prominent players in the market are Quidel Corporation, Abbott Laboratories, Instrumentation Laboratory, BD Biosciences, Roche Diagnostics, Danaher Corporation, Siemens Healthcare, and bioMerieux.
Grand View Research has segmented the global primary care POC diagnostics market on the basis of products, end use, and region: Primary Care POC Diagnostics Product Outlook (Revenue, USD Million, 2014 - 2025) Glucose Testing
Hb1Ac Testing
Coagulation
Fertility
Infectious Diseases
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Decentralized Clinical Chemistry
Feces
Lipid Testing
Cancer Marker
Blood Gas/Electrolytes
Follow Us:
Ambulatory Chemistry
Drug Abuse Testing
Urinalysis
Primary Care POC Diagnostics End-use Outlook (Revenue, USD Million, 2014 - 2025) Pharmacy & Retail Clinics Pharmacy & Retail Clinics, By Product
o
Glucose Testing
Hb1Ac Testing
Coagulation
Fertility
Infectious Diseases
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Decentralized Clinical Chemistry
Feces
Lipid Testing
Cancer Marker
Blood Gas/Electrolytes
Ambulatory Chemistry
Drug Abuse Testing
Urinalysis Physician Office
o
Physician Office, By Product
o
Follow Us:
Glucose Testing
Hb1Ac Testing
Coagulation
Fertility
Infectious Diseases
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Decentralized Clinical Chemistry
Feces
Lipid Testing
Cancer Marker
Blood Gas/Electrolytes
Ambulatory Chemistry
Drug Abuse Testing
Urinalysis Urgent Care Clinics
o
Urgent Care Clinics, By Product
o
o
Follow Us:
Glucose Testing
Hb1Ac Testing
Coagulation
Fertility
Infectious Diseases
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Decentralized Clinical Chemistry
Feces
Lipid Testing
Cancer Marker
Blood Gas/Electrolytes
Ambulatory Chemistry
Drug Abuse Testing
Urinalysis Non-practice Clinics
Non-practice Clinics, By Product
o
Glucose Testing
Hb1Ac Testing
Coagulation
Fertility
Infectious Diseases
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Decentralized Clinical Chemistry
Feces
Lipid Testing
Cancer Marker
Blood Gas/Electrolytes
Ambulatory Chemistry
Drug Abuse Testing
Urinalysis
Primary Care POC Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025) North America
o
U.S.
o
Canada
Europe o
Germany
o
France
o
U.K.
o
Italy
o
Spain
Asia Pacific
Follow Us:
o
China
o
Japan


o
India
o
Korea
o
Australia
o
Singapore
Latin America o
Brazil
o
Mexico
o
Chile
o
Argentina
Middle East & Africa o
South Africa
o
Saudi Arabia
o
UAE
o
Nigeria
o
Qatar
o
Kenya
o
Zimbabwe
Browse Related Category Reports @ www.grandviewresearch.com/industry/clinical-diagnostics
Table of Content of Primary Care POC Diagnostics Market Chapter 1 Research Methodology 1.1 Information Procurement 1.2 Data Analysis Chapter 2 Executive Summary Chapter 3 Primary Care POC Diagnostics Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.1.1 Market driver analysis 3.1.1.1 Increasing adoption as well as accessibility of Point-of-Care Testing (POCT) in primary care settings 3.1.1.2 Rapid advances in POCT for primary care settings 3.1.1.3 Surveys and studies demonstrating POCT for primary care settings & consequent enhanced adoption rate in primary care 3.1.2 Market restraint analysis
Follow Us:
3.1.2.1 High procedure costs coupled with limited adoption of POC devices in certain emerging regions 3.1.2.2 Presence of ambiguous regulatory as well as reimbursement framework for primary care setting 3.2 Penetration & growth prospect mapping for primary care point of care diagnostics end-use,2016 3.3 Primary care point-of-care diagnostics- SWOT analysis, by factor (political & legal, economic and technological) 3.4 Primary care point-of-care diagnostics- Industry analysis Porter’s 3.5 Competitive landscape: Major market participants 3.5.1 Company size 3.5.2 Distribution network 3.5.3 Product portfolio 3.5.4 Segment coverage 3.5.5 Geographic presence 3.5.6 Collaborations (Primary care POC diagnostics) 3.5.7 Conclusion (Primary care POC diagnostics) 3.6 Product Positioning Analysis, 2016 3.6.1 Glucose testing 3.6.2 Hb1Ac testing 3.6.3 Coagulation testing 3.6.4 Fertility 3.6.5 Infectious disease 3.6.6 Cardiac markers 3.6.7 Thyroid 3.6.8 Haematology 3.6.9 Primary Care 3.6.10 Decentralized clinical chemistry 3.6.11 Faecal 3.6.12 Lipid testing 3.6.13 Cancer marker 3.6.14 Blood gas/electrolytes 3.6.15 Ambulatory chemistry 3.6.16 Drug of Abuse (DOA) testing 3.6.17 Urinalysis
Follow Us:
3.7 Marketing Channels 3.7.1 Abbott Diagnostics 3.7.1.1 Alere Inc. 3.7.2 Roche Diagnostics 3.7.3 Siemens Healthcare 3.7.4 Danaher Corporation 3.7.5 Instrumentation Laboratory Spa. 3.7.6 Becton Dickinson Chapter 4 Primary Care POC Diagnostics Market: Product Estimates & Trend Analysis 4.1 Primary Care Point-of-Care Diagnostics Market: Product Movement Analysis 4.2 Primary care POC glucose testing 4.2.1 Global primary care POC glucose testing market, 2014 - 2025 (USD Million) 4.3 Hb1Ac testing. 4.3.1 Global primary care POC Hb1Ac testing market, 2014 - 2025 (USD Million) 4.4 POC coagulation testing 4.4.1 Global primary care POC coagulation testing market, 2014 - 2025 (USD Million) 4.5 POC fertility testing 4.5.1 Global primary care POC fertility testing market, 2014 - 2025 (USD Million) 4.6 Primary Care POC infectious diseases testing 4.6.1 HIV POC 4.6.2 Clostridium difficile POC 4.6.3 HBV POC 4.6.4 Pneumonia or Streptococcus associated infections 4.6.5 Respiratory Syncytial Virus (RSV) POC 4.6.6 HPV POC 4.6.7 Influenza/Flu POC 4.6.8 HCV POC 4.6.9 MRSA POC 4.6.10 HSV POC 4.6.11 TB and drug-resistant TB POC 4.6.12 Other infectious diseases 4.6.13 Global primary care POC infectious disease testing market, 2014 - 2025 (USD Million)
Follow Us:
4.7 POC cardiac markers 4.7.1 Global primary care POC cardiac marker testing market, 2014 - 2025 (USD Million) 4.8 POC thyroid testing 4.8.1 Global primary care POC thyroid testing market, 2014 - 2025 (USD Million) 4.9 Hematology POC testing 4.9.1 Global primary care POC hematology testing market, 2014 - 2025 (USD Million) 4.10 Primary care systems 4.10.1 Global primary care POC testing in primary care settings market, 2014 - 2025 (USD Million) 4.11 Decentralized clinical chemistry POC testing 4.11.1 Global primary care POC decentralized clinical chemistry market, 2014 - 2025 (USD Million) 4.12 Feces POC testing 4.12.1 Global primary care POC fecal testing market, 2014 - 2025 (USD Million) 4.13 Lipid POC 4.13.1 Global primary care POC lipid testing market, 2014 - 2025 (USD Million) 4.14 Primary care POC cancer marker 4.14.1 Global primary care POC cancer marker market, 2014 - 2025 (USD Million) 4.15 Blood gas/electrolytes POC 4.15.1 Global primary care POC blood gas electrolyte tests market, 2014 - 2025 (USD Million) 4.16 Ambulatory chemistry POC 4.16.1 Global primary care POC ambulatory chemistry market, 2014 - 2025 (USD Million) 4.17 Drug abuse POC testing 4.17.1 Global primary care POC drug abuse tests market, 2014 - 2025 (USD Million) 4.18 Urinalysis POC testing 4.18.1 Global primary care POC urinalysis market, 2014 - 2025 (USD Million) Chapter 5 Primary Care POC Diagnostics Market: End use Estimates & Trend Analysis 5.1 Primary Care Point-of-care Diagnostics Market: End use Movement Analysis 5.1.1 Pharmacy & retail clinics 5.1.1.1 Global pharmacy & retail clinics market, 2014 - 2025 (USD Million) 5.1.2 Physician office 5.1.2.1 Global physician office market, 2014 - 2025 (USD Million) 5.1.3 Urgent care clinics 5.1.3.1 Global urgent care clinics market, 2014 - 2025 (USD Million)
Follow Us:
5.1.4 Non-practice clinics 5.1.4.1 Global non-practice clinics market, 2014 - 2025 (USD Million) Chapter 6 Primary Care POC Diagnostics Market: Regional Estimates & Trend Analysis 6.1 Primary care point-of-care diagnostics market share by region, 2016 & 2025 6.2 North America 6.2.1 North America primary care POC diagnostics market, 2014 - 2025 (USD Million) 6.2.2 U.S. 6.2.2.1 U.S. primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.2.2.2 U.S. primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.2.3 Canada 6.2.3.1 Canada primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.2.3.2 Canada primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.3 Europe 6.3.1 Europe primary care POC diagnostics market, 2014 - 2025 (USD Million) 6.3.2 Germany 6.3.2.1 Germany primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.3.2.2 Germany primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.3.3 France 6.3.3.1 France primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.3.3.2 France primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.3.4 U.K. 6.3.4.1 U.K. primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.3.4.2 U.K. primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.3.5 Italy 6.3.5.1 Italy primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.3.5.2 Italy primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.3.6 Spain 6.3.6.1 Spain primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.3.6.2 Spain primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.4 Asia Pacific 6.4.1 Asia Pacific primary care POC diagnostics market, 2014 - 2025 (USD Million) 6.4.2 Japan
Follow Us:
6.4.2.1 Japan primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.4.2.2 Japan primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.4.3 China 6.4.3.1 China primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.4.3.2 China primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.4.4 India 6.4.4.1 India primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.4.4.2 India primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.4.5 Korea 6.4.5.1 Korea primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.4.5.2 Korea primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.4.6 Australia 6.4.6.1 Australia primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.4.6.2 Australia primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.4.7 Singapore 6.4.7.1 Singapore primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.4.7.2 Singaporeprimary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.5 Latin America 6.5.1 Latin America primary care POC diagnostics market, 2014 - 2025 (USD Million) 6.5.2 Brazil 6.5.2.1 Brazil primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.5.2.2 Brazil primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.5.3 Mexico 6.5.3.1 Mexico primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.5.3.2 Mexico primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.5.4 Chile 6.5.4.1 Chile primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.5.4.2 Chile primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.5.5 Argentina 6.5.5.1 Argentina primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.5.5.2 Argentina primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.6 Middle East & Africa.
Follow Us:
6.6.1 MEA primary care POC diagnostics market, 2014 - 2025 (USD Million) 6.6.2 South Africa 6.6.2.1 South Africa primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.6.2.2 South Africa primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.6.3 Saudi Arabia 6.6.3.1 Saudi Arabia primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.6.3.2 Saudi Arabia primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.6.4 UAE 6.6.4.1 UAE primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.6.4.2 UAE primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.6.5 Nigeria 6.6.5.1 Nigeria primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.6.5.2 Nigeria primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.6.6 Qatar 6.6.6.1 Qatar primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.6.6.2 Qatar primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.6.7 Kenya 6.6.7.1 Kenya primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.6.7.2 Kenya primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) 6.6.8 Zimbabwe 6.6.8.1 Zimbabwe primary care POC diagnostics market, by product, 2014 - 2025 (USD Million) 6.6.8.2 Zimbabwe primary care POC diagnostics market, by end-use, 2014 - 2025 (USD Million) Chapter 7 Competitive Landscape: 7.1 Strategy framework 7.2 Market participation categorization 7.3 Company Profiles 7.3.1 F Hoffmann-La Roche Ltd. 7.3.1.1 Company overview 7.3.1.2 Financial performance 7.3.1.3 Product benchmarking 7.3.1.4 Strategic initiatives 7.3.2 Danaher
Follow Us:
7.3.2.1 Company overview 7.3.2.1.1 Radiometer Medical ApS 7.3.2.1.2 HemoCue AB 7.3.2.2 Financial performance 7.3.2.3 Product benchmarking 7.3.2.4 Strategic initiatives 7.3.3 Abbott 7.3.3.1 Company overview 7.3.3.1.1 Alere Inc. 7.3.3.2 Financial performance 7.3.3.3 Product benchmarking 7.3.3.4 Strategic initiatives 7.3.4 Siemens Healthineers 7.3.4.1 Company overview 7.3.4.2 Financial performance 7.3.4.3 Product benchmarking 7.3.4.4 Strategic initiatives 7.3.5 bioMerieux SA 7.3.5.1 Company overview 7.3.5.2 Financial performance 7.3.5.3 Product benchmarking 7.3.5.4 Strategic initiatives 7.3.6 Abaxis 7.3.6.1 Company overview 7.3.6.2 Financial performance 7.3.6.3 Product benchmarking 7.3.6.4 Strategic initiatives 7.3.7 QIAGEN 7.3.7.1 Company overview 7.3.7.2 Financial performance 7.3.7.3 Product benchmarking 7.3.7.4 Strategic initiatives
Follow Us:
7.3.8 Johnson & Johnson Services, Inc. 7.3.8.1 Company overview 7.3.8.2 Financial performance 7.3.8.3 Product benchmarking 7.3.8.4 Strategic initiatives 7.3.9 Nova Biomedical 7.3.9.1 Company overview 7.3.9.2 Financial performance 7.3.9.3 Product benchmarking 7.3.9.4 Strategic initiatives 7.3.10 Instrumentation Laboratory 7.3.10.1 Company overview 7.3.10.1.1 Accriva Diagnostics 7.3.10.1.2 International Technidyne Corporation (ITC) 7.3.10.2 Financial performance 7.3.10.2.1 Financial performance 7.3.10.3 Product benchmarking 7.3.10.4 Strategic Initiatives 7.3.11 Trividia Health, Inc. 7.3.11.1 Company overview 7.3.11.2 Financial performance 7.3.11.3 Product benchmarking 7.3.11.4 Strategic initiatives 7.3.12 OraSure Technologies, Inc. 7.3.12.1 Company overview 7.3.12.2 Financial performance 7.3.12.3 Product benchmarking 7.3.12.4 Strategic initiatives 7.3.13 Quidel Corporation 7.3.13.1 Company overview 7.3.13.2 Financial performance 7.3.13.3 Product benchmarking
Follow Us:
7.3.13.4 Strategic initiatives 7.3.14 Trinity Biotech 7.3.14.1 Company overview 7.3.14.2 Financial performance 7.3.14.3 Product benchmarking 7.3.14.4 Strategic initiatives 7.3.15 Sekisui Diagnostics 7.3.15.1 Company overview 7.3.15.2 Financial performance 7.3.15.3 Product benchmarking 7.3.15.4 Strategic initiatives 7.3.16 BD 7.3.16.1 Company overview 7.3.16.2 Financial performance 7.3.16.3 Product benchmarking 7.3.16.4 Strategic initiatives
Follow Us:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us:
Follow Us: